The development of an integral and global treatment to improve the quality of life in those withType II Diabetes Patients is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.

Inclusion Criteria:

• Adults aged 30 to 70 years.
• Diagnosed with Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA) criteria.
• HbA1c levels between 6.5% and 10% at screening.
• Stable diabetes management regimen (medications and lifestyle) for at least three months prior to enrollment

Exclusion Criteria:

• Presence of severe diabetic complications (e.g., end-stage renal disease, proliferative diabetic retinopathy).
• History of photosensitivity or medical conditions exacerbated by light exposure.
• Use of medications or supplements known to significantly alter glucose metabolism, other than current stable diabetes management.
• Pregnant or lactating women.

Triple (ParticipantCare ProviderOutcomes Assessor)